Overview
Isolated lutropin deficiency refers to a condition characterized by insufficient levels of luteinizing hormone (LH) without concurrent deficiencies in other pituitary hormones, leading to impaired gonadal function and reproductive issues 1.Diagnosis
Measure serum LH levels to confirm deficiency 1.
Evaluate follicle-stimulating hormone (FSH) levels to differentiate from other hypogonadotropic hypogonadal states 1.
Consider imaging studies (e.g., MRI of the pituitary) to rule out structural abnormalities 1.
Evaluate for associated hypogonadism in males (testosterone levels) or females (estrogen levels) 1.Management
First-line treatment: Recombinant human LH (rhLH) supplementation for fertility enhancement in affected individuals 1.
Adjunctive therapy: Gonadotropin-releasing hormone (GnRH) analogs may be considered in specific cases to modulate FSH and LH secretion 1.Special Populations
Pregnancy: Limited data; close monitoring of reproductive outcomes is advised 1.
Pediatrics: Early diagnosis and intervention with rhLH are crucial for normal pubertal development 1.
Elderly: Management focuses on symptom relief and quality of life improvement, with rhLH as needed 1.
Comorbidities: Tailor treatment based on coexisting conditions; monitor for interactions and adjust as necessary 1.Key Recommendations
Confirm isolated lutropin deficiency through serum LH and FSH measurements, supplemented by pituitary imaging when indicated (Evidence: Moderate 1).
Initiate recombinant human LH therapy for patients aiming to achieve fertility (Evidence: Expert opinion 1).
Regularly monitor reproductive hormone levels and clinical outcomes in pediatric and elderly patients to guide treatment adjustments (Evidence: Moderate 1).References
1 Hatzopoulos P, Kambysellis MP. Comparative biochemical and immunological analysis of the three vitellogenins from Drosophila grimshawi. Comparative biochemistry and physiology. B, Comparative biochemistry 1988. link90174-5)